Back to Neuromyelitis Optica Spectrum Disorder

Research record changes

The latest 100 trial status and retraction changes detected since change tracking began. Dates show when RareWays recorded the change, which may be later than the source update. Earlier history is unavailable.

  1. Safety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum Disorder

    NOT YET RECRUITING → RECRUITING

    Recorded 2026-10-07

    View record
  2. A Study to Evaluate IMC-002 in Neuromyelitis Optica Spectrum Disorder (NMOSD) Patients

    NOT YET RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record
  3. FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack

    NOT YET RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record
  4. Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record
  5. A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases

    RECRUITING → WITHDRAWN

    Recorded 2026-10-01

    View record
  6. RETRACTED: New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19

    Retraction flag: retracted

    Recorded 2026-10-01

    View record